Recommended Pages at fool.com
More Hair, Less Reason for It (MRK)
fool.com — “The Motley Fool - Merck's baldness treatment Propecia has sexual side effects.” View full resource at fool.com
Most Recently Shared on April 14, 2012 at 1:19 am By:
More Hair, Less Reason for It: Merck's baldness treatment Propecia has sexual side effects. http://t.co/SAjAC7a8
2 Big Reasons for This Drug's Second Look (ABT, AZN, JNJ, PFE, REGN)
fool.com — “The Motley Fool -” View full resource at fool.com
Most Recently Shared on March 19, 2012 at 9:02 pm By:
Drugs and Devices OW OW Health
2 Big Reasons for This Drug's Second Look - Motley Fool: 2 Big Reasons for This Drug's Second LookMotley F... http://t.co/MRG3SE2C #drug
Is Aging Inventory an Issue for Aegean Marine Petroleum Network? (ANW)
fool.com — “The Motley Fool - Don't just ask, "How much inventory?" Ask, "What kind?"” View full resource at fool.com
Most Recently Shared on December 8, 2011 at 3:43 pm By:
Is Aging Inventory an Issue for Aegean Marine Petroleum Network?: Don't just ask, "How much inventory?" Ask, "Wh... http://t.co/X7QTPm40
Avoid This Biotech Stock (AIS)
fool.com — “The Motley Fool - Our investing community's latest prime pick to avoid: Antares Pharma.” View full resource at fool.com
Most Recently Shared on November 23, 2011 at 12:45 am By:
Urology & Nephrology OW Health
Avoid This Biotech Stock: Our investing community's latest prime pick to avoid: Antares Pharma. http://t.co/efjSXDHV
Medical Devices: Venture Capitalists Lobby to Change FDA Approval Process
fool.com — “The Motley Fool - Do you think these firms stand to benefit from new regulations?” View full resource at fool.com
Most Recently Shared on October 30, 2011 at 4:33 pm By:
Drugs and Devices OW OW Health
Medical Devices: Venture Capitalists Lobby to Change FDA Approval Process - Motley Fool: Medical Devi... http://t.co/PwbeReik #MedDevice
Does HP Need a Poison Pill? (CLX, EBAY, GS, HPQ, RIMM)
fool.com — “The Motley Fool - HP may have tapped Goldman Sachs to defend itself against activist investors.” View full resource at fool.com
Most Recently Shared on September 30, 2011 at 5:12 am By:
Does HP Need a Poison Pill?: HP may have tapped Goldman Sachs to defend itself against activist investors. http://t.co/d0n8vZng
Joint-Venture Acid Reflux (JNJ, MRK, PFE, SNY)
fool.com — “The Motley Fool - Merck ditches its joint venture with Johnson & Johnson.” View full resource at fool.com
Most Recently Shared on September 30, 2011 at 3:10 am By:
Joint-Venture Acid Reflux: Merck ditches its joint venture with Johnson & Johnson. http://t.co/WHbJS3nW
Is Aging Inventory an Issue for AngioDynamics? (ANGO)
fool.com — “The Motley Fool - Don't just ask, "How much inventory?" Ask, "What kind?"” View full resource at fool.com
Most Recently Shared on September 21, 2011 at 5:50 pm By:
ProActivAge, Dr. Phillips is also a Founding Partner of The STRIVE Wellness Corporation, a company whose mission is to improve the functional independence and quality of life of older adults. " /> Dr. Wayne Phillips PhD, Active Health Library, Doctor, Wellness Coach, and Senior Wellness Expert
Is Aging Inventory an Issue for AngioDynamics?: Don't just ask, "How much inventory?" Ask, "What kind?" http://t.co/FPyeHpYQ #aging
Pozen's Digital Marketing Plan: A Prescription for the Pharma Industry? (AZN, JNJ, PEP, POZN, SNY)
fool.com — “The Motley Fool - The company looks to get in tune with social media.” View full resource at fool.com
Most Recently Shared on September 21, 2011 at 1:55 pm By:
ScienceintheTriangle Science Enthusiast
Pozen's digital marketing plan: A prescription for the pharma industry? (MedCityNews) http://t.co/mnM1UgzI #SITT
Make Your Job Work Harder for You
fool.com — “The Motley Fool - You need to make the most of what your employer gives you.” View full resource at fool.com
Most Recently Shared on September 7, 2011 at 12:45 pm By:
healthplaninnovation.com.
www.MartinTrussell.com
" /> Martin Trussell Health Advocate
If you have an HDHP, you'll need to know not only exactly what you're responsible for but also how to set up a health …http://t.co/QUSeped
Pfizer and Bristol-Myers Glide Through (BMY, PFE)
fool.com — “The Motley Fool - Eliquis data looks good.” View full resource at fool.com
Most Recently Shared on August 30, 2011 at 10:19 pm By:
Drugs and Devices OW OW Health
Pfizer and Bristol-Myers Glide Through - Motley Fool: Irish TimesPfizer and Bristol-Myers Glide ThroughMot... http://t.co/yQhz19K #drug
Will the FDA Approve NuPathe's Zelrix? (PATH)
fool.com — “The Motley Fool - FDA will make a decision on Monday … maybe.” View full resource at fool.com
Most Recently Shared on August 27, 2011 at 5:33 am By:
Will the FDA Approve NuPathe's Zelrix?: FDA will make a decision on Monday … maybe. http://t.co/tfdVSwQ
Cardinal Health Sees Opportunity (but Faces Challenges) in Specialty Drugs (CAH)
fool.com — “The Motley Fool - Is Cardinal up for the challenge?” View full resource at fool.com
Most Recently Shared on August 24, 2011 at 4:13 pm By:
Cardinal Health Sees Opportunity (but Faces Challenges) in Specialty Drugs: Is Cardinal up for the challenge? http://t.co/TVy9rNr
A Poke in the Eye From the FDA (BMY, HGSI, PFE, REGN)
fool.com — “The Motley Fool - But Regeneron will be OK.” View full resource at fool.com
Most Recently Shared on August 19, 2011 at 2:10 pm By:
Dr Robert M. Tornambe Plastic Surgeon, Physician, Active Health Library, Doctor, and Surgeon
RT @visionaware: Much discussion about the FDA's 3-mo extension of review time for the macular degeneration drug Eylea: http://t.co/J8p98xv
Talbots Readies for Fight (TLB)
fool.com — “The Motley Fool - Talbots' board adopts a poison pill as private equity firm Sycamore Partners grabs a 9.9% stake in the company.” View full resource at fool.com
Most Recently Shared on August 5, 2011 at 6:00 am By:
Talbots Readies for Fight: Talbots' board adopts a poison pill as private equity firm Sycamore Partners grabs a ... http://bit.ly/nGsvoT
